Disease

FOREIGN POLICY  by Siobhán O'Grady                        April 13, 2015
When the Ebola virus spread from Guinea to Sierra Leone and Liberia last spring, the initial international response was labeled a failure. By the time President Barack Obama ordered troops to the affected countries in September, more than 2,400 people were dead.

But in the United States, where major hospitals prepared for an outbreak, there were only four in-country diagnoses, one of which resulted in a death. And some see the urgency of that response as a lesson in how the government can prepare for another public health hazard: a bioterrorist attack.

Arizona Rep. Martha McSally chairs a House subcommittee that will examine over the next few months the threat of bioterrorist attacks and U.S. preparedness to respond to them. She told Foreign Policy that even if a disease outbreak and the use of a biological agent in a coordinated attack are not completely analogous, the response strains similar systems.

“We can learn lessons from other outbreaks that are naturally occurring,” she said. “We can identify weaknesses in our response and even if it wasn’t terrorism, it presses the system at the same level....”

NBC NEWS  by Maggie Fox                                                                               Feb. 26, 2015

The United States fumbled its response to the Ebola epidemic before it even began, neglecting experiments to make vaccines and drugs against the virus, and cutting funding to key public health agencies, a presidential commission said Thursday.

Americans focused on their own almost nonexistent risk of catching Ebola from travelers instead of pressing to help the truly affected nations, the scathing report from the Presidential Commission for the Study of Bioethical Issues says.

They've been acting against their own best interest, the commission said in its report.

"Both justice and prudence demand that we do our part in combating such devastating outbreaks. Once we recognize our humanitarian obligations and the ability of infectious diseases to travel in our interconnected world, we cannot choose between the ethical and the prudential," it reads.

"Ethics and enlightened interest converge in calling for our country to address epidemics at their source."

CENTER FOR INFECTIOUS DISEASE AND POLICY                                                                   Dec. 9, 2014          
By  Peter M. Sandman, PhD, and Jody Lanard, MD  

In contrast to the Ebola crisis in West Africa, which started in late 2013 and will last well into 2015 or longer, the US "Ebola crisis" was encapsulated in a single month, October 2014. But there may well be US Ebola cases to come, brought here by travelers or returning volunteers. And other emerging infectious diseases will surely reach the United States in the months and years ahead.

So now is a propitious time to harvest some crisis communication lessons from the brief US Ebola "crisis."

We're putting "crisis" in quotation marks because there was never an Ebola public health crisis in the United States, nor was there a significant threat of one. But there was a crisis of confidence, a period of several weeks during which many Americans came to see the official response to domestic Ebola as insufficiently cautious, competent, and candid—and therefore felt compelled to implement or demand additional responses of their own devising....